Calcagno D, Hallett J W, Ballard D J, Naessens J M, Cherry K J, Gloviczki P, Pairolero P C
Department of Surgery, Mayo Medical School, Rochester, Minnesota.
Ann Surg. 1991 Dec;214(6):733-6. doi: 10.1097/00000658-199112000-00015.
Controversy continues over whether patients treated with straight Dacron aortic tube grafts for an abdominal aortic aneurysm remain at significant risk for subsequent development of iliac aneurysm or occlusive disease. To address this issue, the authors performed a population-based analysis of 432 patients who had an abdominal aortic aneurysm diagnosed between 1951 and 1984. Aneurysm repair was performed eventually in 206 patients (48%). To ascertain differences in late development of graft-related complications, iliac aneurysms, and arterial occlusions, the authors compared all tube-graft patients with similar numbers of bifurcated-graft patients matched for age and year of operation. In the tube-graft group, no subsequent clinically evident or autopsy-proven iliac aneurysms or iliac occlusive disease were noted. Over a mean follow-up of 6 years (range, 4 to 18 years), new aortic aneurysms occurred in the proximal aorta in both tube and bifurcated-graft patients (5.0% and 2.5%, respectively). In contrast the cumulative incidence of graft-related complications was higher with a bifurcated prosthesis (12.8%) compared with a straight graft (5.0%) (p = 0.15). These problems generally occurred 5 to 15 years postoperatively and emphasize the need for long-term graft surveillance. The authors conclude that straight tube-grafts for repair of abdominal aortic aneurysms provide excellent late patency with minimal risk of subsequent iliac aneurysm development.
对于接受直筒涤纶主动脉移植管治疗腹主动脉瘤的患者,后续发生髂动脉瘤或闭塞性疾病的风险是否依然很高,目前仍存在争议。为解决这一问题,作者对432例在1951年至1984年间被诊断为腹主动脉瘤的患者进行了基于人群的分析。最终,206例患者(48%)接受了动脉瘤修复手术。为确定移植相关并发症、髂动脉瘤和动脉闭塞的后期发展差异,作者将所有使用直筒移植管的患者与数量相同、年龄和手术年份匹配的分叉移植管患者进行了比较。在直筒移植管组中,未发现后续临床上明显的或经尸检证实的髂动脉瘤或髂动脉闭塞性疾病。在平均6年(范围4至18年)的随访中,直筒移植管和分叉移植管患者的近端主动脉均出现了新的动脉瘤(分别为5.0%和2.5%)。相比之下,分叉假体的移植相关并发症累积发生率(12.8%)高于直筒移植管(5.0%)(p = 0.15)。这些问题通常发生在术后5至15年,强调了长期移植监测的必要性。作者得出结论,用于修复腹主动脉瘤的直筒移植管具有良好的后期通畅率,后续发生髂动脉瘤的风险极小。